FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Woke NFL Asks DHS to Remove Hall of Fame Defender from Clip of Agency Vowing to Stop Migrant Caravan

Inside the neighborhood living on the edge of America’s tech frontier

Watch: Lindsay Clancy’s Defense Team Screams at Black Media Member While Entering Courthouse for Retrial Hearing

Liberal stronghold set to adopt eye-popping minimum wage amid business exodus

Ohio cancer patient sues hospital after surgeon allegedly amputated wrong leg

Utah man released after decades on death row as DNA evidence excludes him from 1985 killing

Repeat offender with lengthy rap sheet accused of gunning down Kentucky trooper during traffic stop

Eric Schmitt defends perjury trap airball at Jack Smith hearing: ‘Not a mistake’

Fox News Hires Former Top Andrew Cuomo Aide Who Helped Run Major Cover-Up

Woman on Death Row for Satanic Murder Says She Feels ‘a Kinship’ with Lindsay Clancy

Boeing lands $20B-plus Navy deal for sixth-generation fighter to deliver ‘absolute air superiority’

Watch: Broncos Stars Team Up to Give ‘All Glory to God’ on Live TV After Wild Comeback Win

‘F— her’: Jasmine Crockett torched by ex-Dem colleague over who she left off endorsement list

Suspect accused of killing Pittsburgh pediatrician sexually assaulted woman hours earlier: police

Watch: NFL Sparks Controversy Again as Mariachi Band Plays Nat’l Anthem on Monday Night Football

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”